Case Study - Pip Implants
INTRODUCTION
As suggested by Grandgenett (2008, p. 1103), business ethics is the way in which companies relate to one another in the business environment. However, Grandgenett goes on to discuss how business ethics also involves how the companies answer to the various stakeholders interests when in an ethical dilemma. Although, it was established by moral philosophers in the 1970s, business ethics is still a “young, growing, and changing field.” (Moriarty, 2008, p. 956).
The issue of consumers’ rights to a safe product that has been manufactured properly is examined. The article that will be examined is the “PIP Implants Scandal” (2012). The PIP implants scandal is about a French manufacturing company “Poly Implant Prothese” who manufactured breast implants out of non-approved silicone gel and distributed to various countries across the world, including the United Kingdom and Australia (http://www.tga.gov.au/safety/alerts-device-breast-implants-120203.htm). The use of non-approved silicone gel led to raptures of the breast implant in some women which exposed skin tissue to the silicone gel (http://www.dailymail.co.uk/health/article-2115439/PIP-scandal-7-000-women-UK-faulty-breast-implants.html).
Since the discovery of PIP implants potential damages, they have been taken of the market which resulted Poly Implant Prothese closing down in 2010 and Jean Claude Mas currently facing charges of “involuntary injury” (http://www.bbc.co.uk/news/world-europe-16736385). Women whose implants have raptured, have had the implants removed but those women in Australia and the United Kingdom who have not had any problems with the implants have been told not to get them removed if they are not causing any tenderness or pain as suggested by the www.tga.gov.au and “PIP Breast Implants” (BBC News, 2012). However, the TGA is encouraging women to consult their surgeon for a follow up if they are unsure (http://www.tga.gov.au/safety/alerts-device-breast-implants-120203.htm).
This
As suggested by Grandgenett (2008, p. 1103), business ethics is the way in which companies relate to one another in the business environment. However, Grandgenett goes on to discuss how business ethics also involves how the companies answer to the various stakeholders interests when in an ethical dilemma. Although, it was established by moral philosophers in the 1970s, business ethics is still a “young, growing, and changing field.” (Moriarty, 2008, p. 956).
The issue of consumers’ rights to a safe product that has been manufactured properly is examined. The article that will be examined is the “PIP Implants Scandal” (2012). The PIP implants scandal is about a French manufacturing company “Poly Implant Prothese” who manufactured breast implants out of non-approved silicone gel and distributed to various countries across the world, including the United Kingdom and Australia (http://www.tga.gov.au/safety/alerts-device-breast-implants-120203.htm). The use of non-approved silicone gel led to raptures of the breast implant in some women which exposed skin tissue to the silicone gel (http://www.dailymail.co.uk/health/article-2115439/PIP-scandal-7-000-women-UK-faulty-breast-implants.html).
Since the discovery of PIP implants potential damages, they have been taken of the market which resulted Poly Implant Prothese closing down in 2010 and Jean Claude Mas currently facing charges of “involuntary injury” (http://www.bbc.co.uk/news/world-europe-16736385). Women whose implants have raptured, have had the implants removed but those women in Australia and the United Kingdom who have not had any problems with the implants have been told not to get them removed if they are not causing any tenderness or pain as suggested by the www.tga.gov.au and “PIP Breast Implants” (BBC News, 2012). However, the TGA is encouraging women to consult their surgeon for a follow up if they are unsure (http://www.tga.gov.au/safety/alerts-device-breast-implants-120203.htm).
This